| 0 (0%) | 11-11 17:43 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 59.49 | 1-year : | 69.48 |
| Resists | First : | 50.93 | Second : | 59.49 |
| Pivot price | 50.79 |
|||
| Supports | First : | 49.77 | Second : | 49.04 |
| MAs | MA(5) : | 50.79 | MA(20) : | 50.68 |
| MA(100) : | 47.31 |
MA(250) : | 45.6 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 61.9 |
D(3) : | 70.9 |
| RSI | RSI(14): 74.7 | |||
| 52-week | High : | 50.93 | Low : | 40.63 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ RESP ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 50.91 - 51.16 | 51.16 - 51.36 |
| Low: | 50.08 - 50.43 | 50.43 - 50.71 |
| Close: | 50.31 - 50.83 | 50.83 - 51.26 |
Tue, 11 Nov 2025
The latest edition of EMJ Respiratory - European Medical Journal
Mon, 10 Nov 2025
Groundbreaking vaccination approach could transform respiratory disease prevention - News-Medical
Fri, 07 Nov 2025
Weekly respiratory virus update, week 44, November 2025 - European Centre for Disease Prevention and Control
Fri, 07 Nov 2025
Helping Patients Breathe Better: Addressing Unmet Needs in Respiratory Care - Sanofi
Thu, 06 Nov 2025
UNC Researchers Uncover Wildfire Smoke’s Impact on Respiratory Health - UNC Health
Thu, 06 Nov 2025
A vision–language pretrained transformer for versatile clinical respiratory disease applications - Nature
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|